XOMA: Message Board for XOMA, Ltd. - InvestorVillage

  • TECH UPDATE: Since we don't serve ads to Premium Members, our "premium" URL is not affected by the new code now required by our ad partners. So, rather than wait for us to resolve all these lovely new code conflicts suddenly plaguing our free, ad-supported "www" pages  (a process which will likely take days), Premium Members can enjoy full site functionality now by simply logging in to their premium accounts at https://premium.investorvillage.com If you need password assistance, don't hesitate to contact us. That's what we're here for.  


LinksY!   Homepage  

XOMA   /  Message Board

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous 97 Messages Top of Message List
Go to Msg #  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
110 Re: A Pump GN fwhco 0 5/3/2019 12:46:29 PM
109 Re: Insider buys GN fwhco 0 12/14/2018 1:19:59 PM
108 Insider buys GN fwhco 0 12/13/2018 11:59:12 AM
107 A Pump GN fwhco 0 11/28/2017 1:15:48 PM
106 Followers? GN fwhco 0 9/6/2017 7:30:35 PM
105 Wedbush Slashes Price Target for XOMA Corp But Remains Positive Following Failed Phase 3 Eyeguard-B Study GN anatporat1 0 7/22/2015 1:38:59 PM
104 Cowen Reiterates Outperform on XOMA Corp Ahead of EYEGUARD-B Trial Results GN anatporat1 2 7/9/2015 9:22:41 AM
103 Wedbush Reiterates Outperform on XOMA Corp Following Orphan Drug Status GN anatporat1 0 6/16/2015 6:29:02 PM
102 Receives Orphan Drug Designatio GN buckiii2 0 6/16/2015 12:04:05 PM
101 Wedbush Reiterates Reiterates Upbeat View of XOMA Corp Following Phase 3 EYEGUARD-B Trial Update GN anatporat2 1 5/28/2015 5:15:47 PM
Previous 97 Messages Top of Message List
Go to Msg #  


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...